Steven G Deeks Selected Research

Steven G Deeks Research Topics

Disease

91	HIV Infections (HIV Infection) 05/2024 - 06/2002
78	Infections 03/2024 - 08/2003
49	Viremia 12/2023 - 01/2002
41	Inflammation (Inflammations) 10/2023 - 12/2006
33	Acquired Immunodeficiency Syndrome (AIDS) 01/2024 - 01/2007
27	COVID-19 04/2024 - 01/2021
16	Disease Progression 01/2020 - 12/2003
10	Post-Acute COVID-19 Syndrome 01/2024 - 01/2022
10	Neoplasms (Cancer) 01/2023 - 09/2012
8	Atherosclerosis 01/2020 - 06/2009
7	Persistent Infection 01/2022 - 06/2006
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2011
5	Virus Diseases (Viral Diseases) 10/2023 - 12/2010
4	Latent Infection 10/2022 - 01/2016
4	Hypertension (High Blood Pressure) 10/2020 - 04/2004
4	Lymphoma (Lymphomas) 01/2018 - 08/2013
3	Tuberculosis (Tuberculoses) 01/2024 - 09/2011
3	Carotid Artery Diseases 01/2020 - 02/2011
3	Fibrosis (Cirrhosis) 01/2017 - 10/2011
3	Coinfection 12/2016 - 09/2009
3	Chronic Disease (Chronic Diseases) 11/2013 - 07/2010
2	Dysbiosis 05/2024 - 07/2013
2	Latent Tuberculosis 01/2024 - 04/2007
2	Asymptomatic Infections 08/2023 - 10/2022
2	Fatigue 01/2023 - 07/2022
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2016
2	Fever (Fevers) 07/2021 - 03/2021
2	Cough 07/2021 - 03/2021
2	Arteritis 01/2021 - 01/2017
2	Myocardial Infarction 01/2019 - 09/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2017 - 02/2012
2	Pulmonary Arterial Hypertension 01/2016 - 02/2014

Drug/Important Bio-Agent (IBA)

58	RNA (Ribonucleic Acid)IBA 12/2023 - 02/2002
17	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 03/2011
17	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2010
13	AntigensIBA 04/2024 - 03/2004
12	CytokinesIBA 01/2023 - 11/2005
11	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2010
11	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2012
10	AntibodiesIBA 11/2023 - 01/2014
9	Antiviral Agents (Antivirals)IBA 11/2023 - 06/2002
9	fibrin fragment D (D-dimer)IBA 12/2016 - 04/2012
8	Lipopolysaccharide ReceptorsIBA 12/2016 - 03/2011
7	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 02/2013
7	Immunoglobulin G (IgG)IBA 01/2023 - 06/2012
7	Peptides (Polypeptides)IBA 10/2021 - 12/2010
6	InterferonsIBA 11/2023 - 04/2007
6	C-Reactive ProteinIBA 01/2021 - 04/2012
5	KynurenineIBA 01/2024 - 07/2013
5	HLA-B Antigens (HLA-B)IBA 01/2024 - 06/2007
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 12/2010
5	VaccinesIBA 01/2022 - 01/2011
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
5	Protease Inhibitors (Protease Inhibitor)IBA 02/2017 - 08/2003
5	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 03/2006
4	COVID-19 VaccinesIBA 11/2023 - 08/2021
4	Broadly Neutralizing AntibodiesIBA 11/2023 - 01/2019
4	Clostridium perfringens epsilon-toxinIBA 03/2023 - 06/2022
3	EpitopesIBA 01/2024 - 01/2020
3	Neutralizing AntibodiesIBA 11/2023 - 06/2006
3	AutoantibodiesIBA 11/2023 - 01/2023
3	Interleukin-17 (Interleukin 17)IBA 01/2023 - 05/2010
3	Viral ProteinsIBA 01/2020 - 08/2017
3	Interferon-gamma (Interferon, gamma)IBA 12/2017 - 09/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 07/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 07/2014
3	LipopolysaccharidesIBA 11/2014 - 01/2008
3	Tenofovir (Viread)FDA Link 06/2014 - 06/2011
3	HLA-C Antigens (HLA-C)IBA 12/2013 - 12/2009
3	abacavir (Ziagen)FDA Link 11/2012 - 09/2009
2	vesatolimodIBA 05/2024 - 01/2021
2	nirmatrelvirIBA 01/2024 - 01/2022
2	Interferon Type IIBA 10/2023 - 01/2017
2	ProteomeIBA 02/2023 - 01/2023
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 02/2023 - 01/2023
2	AutoantigensIBA 02/2023 - 01/2023
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2023 - 07/2022
2	Nucleic AcidsIBA 10/2022 - 03/2021
2	Oxygen (Dioxygen)IBA 07/2021 - 03/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2020 - 11/2014
2	Indicators and Reagents (Reagents)IBA 02/2020 - 03/2012
2	HLA-B57 antigenIBA 01/2020 - 11/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2015
2	CCR5 Receptors (CCR5 Receptor)IBA 01/2019 - 08/2015
2	Brentuximab VedotinIBA 12/2018 - 01/2018
2	ChemokinesIBA 01/2018 - 01/2016
2	PerforinIBA 01/2018 - 03/2006
2	HIV AntibodiesIBA 01/2018 - 01/2017
2	LigandsIBA 01/2017 - 02/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017 - 04/2015
2	Chemokine ReceptorsIBA 01/2016 - 04/2012
2	Disulfiram (Antabuse)FDA Link 12/2015 - 03/2014

Therapy/Procedure

84	Therapeutics 10/2023 - 01/2002
35	Art Therapy 05/2024 - 11/2005
18	Highly Active Antiretroviral Therapy (HAART) 03/2023 - 06/2002
3	Aftercare (After-Treatment) 01/2024 - 01/2004
3	Immunotherapy 01/2024 - 01/2020
2	Duration of Therapy 01/2020 - 11/2005
2	Secondary Prevention 02/2016 - 09/2009